These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6770307)

  • 1. [Storage diseases. Gangliosidosis and mucopolysaccharidosis].
    Feo F
    Minerva Med; 1980 May; 71(20):1469-72. PubMed ID: 6770307
    [No Abstract]   [Full Text] [Related]  

  • 2. Gangliosidoses and the fetal retina.
    Cogan DG; Kuwabara T; Kolodny E; Driscoll S
    Ophthalmology; 1984 May; 91(5):508-12. PubMed ID: 6330639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular degradation of sulforhodamine-GM1: use for a fluorescence-based characterization of GM2-gangliosidosis variants in fibroblasts and white blood cells.
    Agmon V; Khosravi R; Marchesini S; Dinur T; Dagan A; Gatt S; Navon R
    Clin Chim Acta; 1996 Mar; 247(1-2):105-20. PubMed ID: 8920231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [GM2 gangliosidosis].
    Tsuji S
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):177-9. PubMed ID: 10434623
    [No Abstract]   [Full Text] [Related]  

  • 5. Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis.
    Jeyakumar M; Thomas R; Elliot-Smith E; Smith DA; van der Spoel AC; d'Azzo A; Perry VH; Butters TD; Dwek RA; Platt FM
    Brain; 2003 Apr; 126(Pt 4):974-87. PubMed ID: 12615653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manifestation of infantile GM1 gangliosidosis in the fetal eye. An electron microscopic study.
    Schmitt-Gräff A
    Graefes Arch Clin Exp Ophthalmol; 1988; 226(1):84-8. PubMed ID: 3125087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis.
    Sango K; McDonald MP; Crawley JN; Mack ML; Tifft CJ; Skop E; Starr CM; Hoffmann A; Sandhoff K; Suzuki K; Proia RL
    Nat Genet; 1996 Nov; 14(3):348-52. PubMed ID: 8896570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gangliosidoses: comparative features and research applications.
    Baker HJ; Reynolds GD; Walkley SU; Cox NR; Baker GH
    Vet Pathol; 1979 Nov; 16(6):635-49. PubMed ID: 116415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amniotic tissue transplantation as a trial of treatment in some lysosomal storage diseases.
    Tylki-Szymańska A; Maciejko D; Kidawa M; Jabłońska-Budaj U; Czartoryska B
    J Inherit Metab Dis; 1985; 8(3):101-4. PubMed ID: 3939584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.
    Schwarzmann G; Wendeler M; Sandhoff K
    Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cherry-red spot, optic atrophy and corneal cloudings in a patient suffering from GM1 gangliosidosis type I.
    Sorcinelli R; Sitzia A; Loi M
    Metab Pediatr Syst Ophthalmol (1985); 1987; 10(3):62-3. PubMed ID: 3123871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors of phenotypic polymorphism and genetic consultation in thesaurismoses (review)].
    Aĭngorn ED; Timonina OV; Koroleva IA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(10):1564-71. PubMed ID: 6776723
    [No Abstract]   [Full Text] [Related]  

  • 13. Ultrastructural study of biopsy specimens of rectal mucosa. Its use in neuronal storage diseases.
    Yamano T; Shimada M; Okada S; Yutaka T; Kato T; Yabuuchi H
    Arch Pathol Lab Med; 1982 Dec; 106(13):673-7. PubMed ID: 6897182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathology of late onset gangliosidoses. A review.
    Suzuki K
    Dev Neurosci; 1991; 13(4-5):205-10. PubMed ID: 1817025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periodate oxidation of glycolipids: a borohydride-periodate-Schiff method for ganglioside demonstration in tissue sections.
    Buk SJ; High OB
    Histochem J; 1986 May; 18(5):228-32. PubMed ID: 3091539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain gangliosides: an improved simple method for their extraction and identification.
    Randell JA; Pennock CA
    J Chromatogr; 1980 Jul; 195(2):257-64. PubMed ID: 6773970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM1 gangliosidosis: phenotypic variation in a single family.
    Farrell DF; Ochs U
    Ann Neurol; 1981 Mar; 9(3):225-31. PubMed ID: 6784662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Generalized GM1 gangliosidosis. Report of a case and review of the literature].
    Pérez R; Cuesta JM; Haro de los Monteros N; Hernando Mayor y Montes JC
    An Esp Pediatr; 1984 May; 20(8):783-8. PubMed ID: 6433763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.
    Tsuji D; Higashine Y; Matsuoka K; Sakuraba H; Itoh K
    Clin Chim Acta; 2007 Mar; 378(1-2):38-41. PubMed ID: 17196574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G(M1)-ganglioside degradation and biosynthesis in human and murine G(M1)-gangliosidosis.
    Sano R; Trindade VM; Tessitore A; d'Azzo A; Vieira MB; Giugliani R; Coelho JC
    Clin Chim Acta; 2005 Apr; 354(1-2):131-9. PubMed ID: 15748609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.